ERRFI1 and acute kidney injury: Furthermore, exposure to each inhibitor (LY294002, AKI, rapamycin, or U0126, at lower dose indicated above) increased the ratio of phospho-EGFR to EGFR (Figure 2F and 2G) upon ligand stimulation, consistent with the role of Mig6 in regulating EGFR activity.